The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.17 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
Camlin Fine Sciences has a Altman Z-Score of 2.14, indicating it is in Grey Zones. This implies that Camlin Fine Sciences is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Camlin Fine Sciences's Altman Z-Score or its related term are showing as below:
NSE:CAMLINFINE'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.68 Med: 2.31 Max: 2.93
Current: 2.17
During the past 13 years, Camlin Fine Sciences's highest Altman Z-Score was 2.93. The lowest was 1.68. And the median was 2.31.
Camlin Fine Sciences (NSE:CAMLINFINE) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Camlin Fine Sciences Altman Z-Score Related Terms
Camlin Fine Sciences Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Camlin Fine Sciences's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAMLINFINE vs LIN, SHW, ECL: Altman Z-Score Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences Altman Z-Score vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Camlin Fine Sciences's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1128
+
1.4
*
0
+
3.3
*
0.0167
+
0.6
*
1.9796
+
1.0
*
0.7597
=
2.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Camlin Fine Sciences (NSE:CAMLINFINE) has a Altman Z-Score of 2.14 as of Jun. 27, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Camlin Fine Sciences and its competitors. This is near median its historical median of 2.31. Over the past decade, Camlin Fine Sciences' Altman Z-Score has ranged from 1.68 to 2.93. According to the industry distribution chart, Camlin Fine Sciences ranks #1072 out of 1572 companies in the Chemicals industry, placing it in the top 68.2%.
Is Camlin Fine Sciences' Altman Z-Score too high?
Camlin Fine Sciences' current Altman Z-Score of 2.14 is near median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 1.68 to a high of 2.93. The Chemicals industry median Altman Z-Score is 3.18. Camlin Fine Sciences' value of 2.14 is 32.6% below this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #1072 out of 1572 companies in the Chemicals industry, which is below the industry midpoint. Overall, Camlin Fine Sciences has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' Altman Z-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #1072 out of 1572 companies for Altman Z-Score. This places Camlin Fine Sciences in the lower half of its industry. The industry median Altman Z-Score is 3.18. Camlin Fine Sciences' value of 2.14 is 32.6% below this benchmark. Historically, Camlin Fine Sciences' own Altman Z-Score has ranged from 1.68 to 2.93 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 3.18, Camlin Fine Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Chemicals company?
The median Altman Z-Score among Chemicals companies is 3.18, based on 1,572 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current Altman Z-Score of 2.14 is 32.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Camlin Fine Sciences and its competitors. For the Chemicals industry, the median Altman Z-Score is 3.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current Altman Z-Score is 2.14, which is near median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹142.22, compared to a current price of ₹136.37 — trading 4.1% below its estimated fair value. The current Altman Z-Score is 2.14, which is near median its 10-year median of 2.31 and 32.6% below the Chemicals industry median of 3.18. Camlin Fine Sciences' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current Altman Z-Score is 2.14 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹136.37 is trading 4.1% below its estimated GF Value™ of ₹142.22.
GuruFocus considers Camlin Fine Sciences to be Fairly Valued.
Key valuation signals for NSE:CAMLINFINE:
Altman Z-Score: 2.14 (near median its 10-year median of 2.31)
GF Value™: ₹142.22 vs. price of ₹136.37 (4.1% below fair value)
Industry Position: 32.6% below the Chemicals median (#1072 of 1572)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
58GF Score
Get the complete analysis for NSE:CAMLINFINE
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
